Page last updated: 2024-08-24

plerixafor and Carcinoma, Neuroendocrine

plerixafor has been researched along with Carcinoma, Neuroendocrine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dizdar, L; Forster, CM; Knoefel, WT; Krieg, A; Raba, K; Schott, M; Verde, PE; Werner, TA1

Other Studies

1 other study(ies) available for plerixafor and Carcinoma, Neuroendocrine

ArticleYear
CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
    British journal of cancer, 2017, Dec-05, Volume: 117, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminopyridines; Antigens, CD; Benzylamines; Cadherins; Carcinoma, Neuroendocrine; Cell Cycle; Cell Line, Tumor; Chemokine CXCL12; Child; Cyclams; Epithelial-Mesenchymal Transition; Female; Fibroblast Growth Factor 9; Gene Expression; GPI-Linked Proteins; Heterocyclic Compounds; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Phenotype; Prognosis; Receptors, CXCR; Receptors, CXCR4; Recombinant Proteins; Retrospective Studies; Snail Family Transcription Factors; Survival Rate; Thyroid Neoplasms; Tissue Array Analysis; Tumor Burden; Vimentin; Young Adult

2017